###
中国临床研究:2026,39(8):1288-1294
本文二维码信息
码上扫一扫!
SERPINA1在肿瘤中的功能异质性及临床应用
(南通大学医学院病理学系, 江苏 南通 226001)
Functional heterogeneity and clinical application of SERPINA1 in tumors
(Department of Pathology,Medical School of Nantong University,Nantong,Jiangsu 226001,China)
摘要
本文已被:浏览 279次   下载 247次
投稿时间:2026-05-30   网络发布日期:2026-08-25
中文摘要: 丝氨酸蛋白酶抑制剂A1(SERPINA1)又称α1-抗胰蛋白酶,是丝氨酸蛋白酶抑制剂超家族的重要成员,主要参与蛋白酶-抗蛋白酶平衡、炎症反应、组织修复及免疫调节。近年来研究发现,SERPINA1 在多种实体瘤中异常表达,并与肿瘤增殖、侵袭、转移、上皮-间质转化、免疫逃逸及患者预后密切相关。值得注意的是,SERPINA1 在不同肿瘤中呈现明显异质性,既可通过PI3K/AKT/NF-κB、JAK/STAT3、MAPK/AKT/mTOR等通路发挥促癌作用,也能在特定肿瘤背景下表现出抑癌效应。本文围绕SERPINA1的分子特征、肿瘤表达谱、信号通路调控、肿瘤微环境相互作用、表观遗传及蛋白稳态调控机制进行综述,并探讨其作为肿瘤诊断、预后评估和治疗靶点的潜在价值,以期为SERPINA1相关肿瘤研究和精准诊疗提供参考。
Abstract:Serine protease inhibitor A1(SERPINA1),also known as α1-antitrypsin,is a vital member of the serine protease inhibitor superfamily. It mainly participates in protease - antiprotease balance,inflammatory response,tissue repair and immune regulation.Recent studies have revealed that SERPINA1 is aberrantly expressed in multiple solid tumors,and it is closely associated with tumor proliferation,invasion,metastasis,epithelial-mesenchymal transition,immune evasion,and patient prognosis. Notably,SERPINA1 exhibits prominent heterogeneity across various cancer types. It exerts oncogenic effects via multiple signaling pathways including PI3K/AKT/NF-κB,JAK/STAT3 and MAPK/AKT/mTOR,while it may also exert tumor-suppressive effects under specific tumor contexts.This review systematically summarizes the molecular characteristics,tumor expression profiles,regulation of signaling pathways,crosstalk with tumor microenvironment,epigenetic regulation and protein homeostasis regulatory mechanisms of SERPINA1.Additionally,it discusses its potential value as a biomarker for tumor diagnosis,prognostic evaluation and therapeutic target,so as to provide references for SERPINA1-related oncological research and precision diagnosis and treatment.
文章编号:     中图分类号:R73    文献标志码:A
基金项目:国家自然科学基金(81572871)
附件
引用文本:
白晨晞, 蒯兴旺, 张可, 陈垦, 季菊玲.SERPINA1在肿瘤中的功能异质性及临床应用[J].中国临床研究,2026,39(8):1288-1294.

用微信扫一扫

用微信扫一扫